Comparing two surgical methods for treating gallbladder cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of wedge resection versus bisegmentectomy in patients with T2 or T3 gallbladder cancer. Patients are randomly assigned to one of the two surgical approaches, with a total of 88 participants. The primary focus is on evaluating recurrence-free survival rates and overall survival rates following the surgeries. Both procedures involve similar lymph node dissection techniques, ensuring that the only variable is the extent of liver resection performed.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with T2 or T3 gallbladder cancer on preoperative CT exam
* Patients who are pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy

Exclusion Criteria:

* Peritoneal seeding or distant metastasis
* Impossible to resect the cancer radically
* Pathologically diagnosed to other malignancy such as adenosquamous carcinoma, sarcoma, etc.
* R1 or R2 resection were pathologically diagnosed.

Where it's running

• the Catholic University of Korea St. Vincent's Hospital
  Suwon, South Korea Recruiting

Study contacts

• Study coordinator: Dong Do You, MD, PhD
• Email: tzanggu@catholic.ac.kr
• Phone: 82-31-249-8303

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CD160-Enhanced Autologous T Cells for Advanced Biliary Tract Cancer

  This trial tests a patient‑made T cell therapy (BTC-Ag-T) to see if it is safe and can help people with advanced biliary tract cancer who have exhausted standard treatments.

  Recruiting Phase 1 Shanghai Zhongshan Hospital · Shanghai · NCT07614061

• Testing MDX2001 for advanced solid tumors

  This study is testing a new drug called MDX2001 to see if it can safely help people with advanced solid tumors like breast or colon cancer.

  Recruiting at 6 sites Phase 1/2 ModeX Therapeutics, An OPKO Health Company · Denver, Colorado and 5 other locations · NCT06239194

• Identifying risk factors for gallbladder cancer and gallstone disease

  This study is trying to find out what causes gallbladder cancer and gallstone disease by looking at different lifestyle and genetic factors to help with early detection and prevention.

  Recruiting at 36 sites Centre Paul Strauss · Salta and 35 other locations · NCT06192719

• Comparing two methods of pain management during laparoscopic gallbladder surgery

  This study is testing whether a new pain management method that combines two techniques can help people feel less pain after gallbladder surgery compared to just one technique.

  Recruiting Helsinki University Central Hospital · Espoo, Uusimaa · NCT06123117

• Combining four drugs for treating unresectable gallbladder cancer

  This study is testing a combination of four drugs to see if it can help people with gallbladder cancer that can't be removed by surgery.

  Recruiting Phase 2 Fudan University · Shanghai · NCT05757336

• Exploring genetic factors in gallbladder cancer treatment responses

  This study is trying to see how certain genetic changes in people with gallbladder cancer affect how well they respond to treatment.

  Recruiting Banaras Hindu University · Varanasi, Uttar Pradesh · NCT05404347

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.